title: Protection by glutathione of neutrophils against the toxic effects of peritoneal dialysis fluid.
abstract: The possibility of reducing the cytotoxic effect of heat-sterilized peritoneal dialysis (PD) fluid by addition of antioxidants/scavengers during incubation of titanium-adhering cells was investigated. Capillary blood from healthy donors was placed in drops on commercially available titanium pieces and incubated in a humidified chamber at 37 degrees C for 60min. After incubation the adherent polymorphonuclear leukocytes were immersed for 1-4h in PD-fluid, pH 7.4, containing 2.5% glucose with glutathione (GSH), superoxide dismutase, catalase or dithiothreitol (DTT). Luminol- or isoluminol-amplified chemiluminescence was used to measure the zymosan- and phorbol myristate acetate (PMA)-stimulated respiratory burst activity, as an indicator of the cytotoxicity of the PD-fluids. Heat sterilized PD-fluid had inhibitory effect on zymosan-induced respiratory burst and impaired both the extracellular and intracellular PMA-induced respiratory burst. Addition of GSH to the PD-fluid resulted in reduction of cytotoxical effects on the zymosan-induced and extracellular PMA-induced respiratory burst. The intracellular respiratory burst was not affected. The present results show that GSH and DTT have the ability to protect polymorphonuclear leukocytes against the cytotoxic effects of the PD-fluid by keeping the cell membrane in a reduced state.
authors.affiliation: Applied Cell Biology, Institute of Anatomy and Cell Biology, University of Göteborg, Sweden.
authors.forename: N
authors.initials: N
authors.lastname: Yahyapour
authors.forename: C
authors.initials: C
authors.lastname: Eriksson
authors.forename: P
authors.initials: P
authors.lastname: Kjellstrand
authors.forename: A
authors.initials: A
authors.lastname: Wieslander
authors.forename: H
authors.initials: H
authors.lastname: Nygren
mesh_terms: D002374:Catalase / Q000494:pharmacology; D002448:Cell Adhesion; D002470:Cell Survival / Q000187:drug effects; D019610:Cytoprotection / Q000187:drug effects*; D015314:Dialysis Solutions / Q000009:adverse effects*; D004229:Dithiothreitol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005978:Glutathione / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008163:Luminescent Measurements; D009504:Neutrophils / Q000187:drug effects* / Q000378:metabolism; D010530:Peritoneal Dialysis; D016897:Respiratory Burst; D013242:Sterilization / Q000379:methods; D013482:Superoxide Dismutase / Q000494:pharmacology; D013499:Surface Properties; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014025:Titanium; D015054:Zymosan / Q000494:pharmacology
chemical_list: D015314:Dialysis Solutions; D015054:Zymosan; D014025:Titanium; D002374:Catalase; D013482:Superoxide Dismutase; D005978:Glutathione; D013755:Tetradecanoylphorbol Acetate; D004229:Dithiothreitol